Drugs News and Research

RSS

KIYATEC enrolls first patients with solid tumors in clinical study of its EV3D drug response assay

KIYATEC, Inc. today announced the enrollment of the first patients in a U.S. clinical study of its Ex Vivo 3D drug response assay across several difficult-to-treat solid tumors.

20 Jun 2018

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

A new study by iData Research estimates that there are nearly 150,000 new cases of psoriasis every year in the United States, affecting 2.2% of the population.

20 Jun 2018

Targeting cells involved in blood vessel formation could hinder brain tumor growth

A type of highly malignant brain tumor contains a large number of cells involved in the formation of new blood vessels, helping it proliferate and spread.

20 Jun 2018

Combining stem cell technology and artificial intelligence to diagnose genetic cardiac diseases

A new study by Professors Martti Juhola and Katriina Aalto-Setälä of the University of Tampere in Finland demonstrates that with the use of artificial intelligence and machine learning, it is possible not only to accurately sort sick cardiac cell cultures from healthy ones, but also to differentiate between genetic cardiac diseases.

20 Jun 2018

Researchers characterize key signaling network that drives growth of triple negative breast cancers

It's called the 'kiss of death'. Triple negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy.

20 Jun 2018

UH scientist receives grant to examine understudied part of glaucoma

UH College of Optometry biomedical engineer Vijaykrishna Raghunathan has received $765,000 from the National Institutes of Health to examine an understudied part of glaucoma - the ebb and flow of aqueous humor, the liquid in the eye whose regulation controls eye pressure.

20 Jun 2018

OHSU Knight Cancer Institute Director wins 2018 Tang Prize in Biopharmaceutical Science

OHSU Knight Cancer Institute Director Brian J. Druker, M.D., has been awarded the 2018 Tang Prize in Biopharmaceutical Science for his pioneering role in shaping the fields of precision medicine and targeted cancer drugs.

20 Jun 2018

Religious involvement has no significant effect on misuse of prescription opioids, study finds

Does going to church help people avoid struggles with opioid abuse? New research from Florida State University says no.

20 Jun 2018

Methadone or buprenorphine associated with reductions in opioid related mortality

A National Institutes of Health-funded study found that treatment of opioid use disorder with either methadone or buprenorphine following a nonfatal opioid overdose is associated with significant reductions in opioid related mortality.

19 Jun 2018

Hypnosis may help reduce fear, anxiety in children undergoing treatment for cancer

Hypnosis could help to reduce the fear of medical procedures in children and young people with cancer.

19 Jun 2018

Study provides new insight on how antibiotics affect the gut microbiome

New insight on how antibiotics affect the gut microbiome - the community of microbes that live inside us - has been published in the journal eLife.

19 Jun 2018

Inhibiting epigenetic proteins with drugs could prevent development of breast cancer

Researchers at the Princess Margaret Cancer Centre in Toronto have discovered that epigenetic proteins promote the proliferation of mammary gland stem cells in response to the sex hormone progesterone.

19 Jun 2018

Study introduces novel strategy to obtain reasonable drug cost estimates for cost-effectiveness analyses

Value in Health, the official journal of ISPOR, announced today the publication of a study introducing a novel strategy for obtaining reasonable drug cost estimates for US-based cost-effectiveness analyses

19 Jun 2018

Clinical trial targets metastatic colorectal cancer with new combination therapy

Rutgers Cancer Institute of New Jersey is offering a clinical trial targeting an advanced form of colorectal cancer with a combination vaccine/immunotherapy drug treatment.

19 Jun 2018

SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis

SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced positive long-term data for its first-in-human study using bioelectronic medicine for rheumatoid arthritis

19 Jun 2018

FDA provides guidance on Novus Therapeutics’ development path for OP-02 to treat otitis media

Novus Therapeutics, Inc., a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat, announced receipt of final meeting minutes from the U.S. Food and Drug Administration following a Type C meeting held at the Company's request to discuss its OP-02 development program in otitis media.

19 Jun 2018

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.

19 Jun 2018

After opioid overdose, only 30 percent get medicine to treat addiction

More than 115 Americans die every day of opioid overdose. Many more survive thanks to the antidote medication, naloxone. But a study out Monday finds that just 3 in 10 patients revived by an EMT or in an emergency room received the follow-up medication known to avoid another life-threatening event.

19 Jun 2018

Scientists create universal assembly method to enhance cancer therapy and diagnostics

Biophysicists have developed a method for modifying the surface of micro- and nanoparticles — tiny structures measuring between a thousandth and a millionth of a millimeter — by covering them with biological molecules. Engineered in this way, the particles can serve as both therapeutic and diagnostic agents, delivering drugs to cancer cells.

19 Jun 2018

Chemists invent new method for remote chiral induction

Chemists at Scripps Research have addressed one of the most formidable challenges in synthetic chemistry by inventing a method for "enantioselective remote meta-CH activation," which enables the making of chiral molecules that were previously difficult or impossible to synthesize.

19 Jun 2018

Drugs News and Research

KIYATEC enrolls first patients with solid tumors in clinical study of its EV3D drug response assay

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

Targeting cells involved in blood vessel formation could hinder brain tumor growth

Combining stem cell technology and artificial intelligence to diagnose genetic cardiac diseases

Researchers characterize key signaling network that drives growth of triple negative breast cancers

UH scientist receives grant to examine understudied part of glaucoma

OHSU Knight Cancer Institute Director wins 2018 Tang Prize in Biopharmaceutical Science

Religious involvement has no significant effect on misuse of prescription opioids, study finds

Methadone or buprenorphine associated with reductions in opioid related mortality

Hypnosis may help reduce fear, anxiety in children undergoing treatment for cancer

Study provides new insight on how antibiotics affect the gut microbiome

Inhibiting epigenetic proteins with drugs could prevent development of breast cancer

Study introduces novel strategy to obtain reasonable drug cost estimates for cost-effectiveness analyses

Clinical trial targets metastatic colorectal cancer with new combination therapy

SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis

FDA provides guidance on Novus Therapeutics’ development path for OP-02 to treat otitis media

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

After opioid overdose, only 30 percent get medicine to treat addiction

Scientists create universal assembly method to enhance cancer therapy and diagnostics

Chemists invent new method for remote chiral induction

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News